United States · Funded startup

Who invested in Domus Diagnostics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.4Mraised across 1 round since 2023, from 1 source

Latest round
Grant, $2.4MMay 2023
Investors
2
See who backed them

The rounds

  1. May 2023

Founders and team

From Domus Diagnostics's own website: 1 founder, 6 on the team.

Harald Casebourne StockCo-Founder & Executive Chair, Board of Directors
  • Dan MorganLead | Design for Manufacturing
  • Jackie WalejkoResearch Scientist
  • Josh BeckmannLead | Design Engineering
  • Josh BuserLead | Device Integration
  • Will BrownSystems Integration Engineer, Professional Platform
  • Paul ChapmanTeam

AdvisersBrandon JohnsonJoe GentileJohn Reif

Everyone who backed them

Bantam GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Domus Diagnostics

Who invested in Domus Diagnostics?

Domus Diagnostics's investors include National Institutes of Health and Bantam Group.

How much has Domus Diagnostics raised?

Domus Diagnostics has raised $2.4M across 1 round since 2023.

When did Domus Diagnostics last raise?

Domus Diagnostics's most recent round was a Grant of $2.4M in May 2023.

What was Domus Diagnostics's biggest round?

Its most recent round, $2.4M in May 2023, is also its largest on record.

Who backed Domus Diagnostics first?

Domus Diagnostics's first round on record, in May 2023, was backed by National Institutes of Health and Bantam Group.

What stage is Domus Diagnostics at?

Domus Diagnostics's latest named round is a Grant, in May 2023.

Where is Domus Diagnostics based?

Domus Diagnostics is based in the United States.

Companies like Domus Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.